Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study

Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study

Abstract Introduction We evaluated the efficacy and safety of teneligliptin compared with placebo when added to metformin therapy in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy. Methods This multicentre, randomized, double‐blind, placebo‐controlled, paral...

Full description

Bibliographic Details
Main Authors: Linong Ji, Ling Li, Jianhua Ma, Xuefeng Li, Dongmei Li, Bangzhu Meng, Weiping Lu, Jiao Sun, Yanmei Liu, Gen Takayanagi, Yi Wang
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
diabetes mellitus
dipeptidyl peptidase‐IV inhibitors
metformin
type 2
Online Access:https://doi.org/10.1002/edm2.222

Internet

https://doi.org/10.1002/edm2.222

Similar Items